Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
content:epileptic_encephalopathies [2020/02/16 21:35] – [Presenting with seizures associatd with movement disorders] icna | content:epileptic_encephalopathies [2022/04/30 11:54] (current) – changed pubmed syntax administrator@icnapedia.org | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | Approach | + | ====== Epileptic encephalopathies ====== |
+ | Epileptic encephalopathies are a heterogenous group of conditions where the epileptic activity itself contributes to severe cognitive and behavioral impairments above and beyond what might be expected from the underlying pathology alone (e.g., cortical malformation), | ||
+ | |||
+ | The report of the International League Against Epilepsy (ILAE) Task Force on classification and terminology includes 8 syndromes under epileptic encephalopathies: | ||
+ | * [[Early Myoclonic Encephalopathy]] | ||
+ | * [[Early Infantile Epileptic Encephalopathy]] ([[Ohtahara Syndrome]]) | ||
+ | * [[Epilepsy of infancy with migrating focal seizures]] | ||
+ | * [[West Syndrome]] | ||
+ | * [[Dravet Syndrome]] | ||
+ | * [[Epilepsy with Myoclonic Astatic Seizures]] | ||
+ | * [[Lennox-Gastaut Syndrome]] | ||
+ | * [[Epilepsy with Continuous Spike-Waves during Slow Wave Sleep]] including [[Landau-Kleffner Syndrome]] and [[Atypical Benign Partial Epilepsy]]. | ||
+ | |||
+ | One approach | ||
==== Presenting with seizures as prominent/ | ==== Presenting with seizures as prominent/ | ||
* Vitamin or enzymatic cofactor dependency | * Vitamin or enzymatic cofactor dependency | ||
Line 21: | Line 35: | ||
* [[GABA transaminase deficiency]] | * [[GABA transaminase deficiency]] | ||
- | ==== Presenting with seizures associated | + | ==== Presenting with seizures associated |
- | * **Chromosomopathies** | + | * **Chromosomal abnormalities** |
* [[1p36 monosomy]] | * [[1p36 monosomy]] | ||
* [[Wolf-Hirschhorn syndrome]] | * [[Wolf-Hirschhorn syndrome]] | ||
Line 61: | Line 75: | ||
* [[4-hydroxybutyric aciduria]] (SSADH) | * [[4-hydroxybutyric aciduria]] (SSADH) | ||
- | ==== Presenting with seizures associated with acute multiorgan involvement ==== | + | ==== Presenting with seizures associated with multiorgan involvement ==== |
* **Acute multiorgan involvement** | * **Acute multiorgan involvement** | ||
* Endogenous toxicity | * Endogenous toxicity |